Clinical Trial Update: Efficacy Study in Lumbosacral Radiculopathy [Phase 2]

View source ↗

Summary

Phase 2 efficacy study in lumbosacral radiculopathy sponsored by GlaxoSmithKline has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbosacral Radiculopathy
• Neuropathic Pain

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pain, Neuropathic | Phase 2 | Status: COMPLETED